{"id":1441,"name":"Aperture Venture Partners","slug":"aperture-venture-partners","website":"https://www.apertureventurecapital.com","hqGeo":"Denver, CO","stageFocus":["Pre-Seed","Seed"],"sectorTags":["SaaS","AI / ML","Enterprise"],"excludedSectors":[],"checkSizeMin":500000,"checkSizeMax":3000000,"thesisSummary":"Focused on applied AI within B2B SaaS applications, particularly in sectors like hospitality and customer personalization.","thesisNarrative":null,"logoUrl":null,"aumUsd":101000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"InsightsNow","companyUrl":null,"stage":null,"sector":"AI Personalization","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"WelcomeOS","companyUrl":null,"stage":null,"sector":"Hospitality Tech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Anonybit","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Anonybit and Scamnetic Partner to Launch Privacy-Preserving Biometric Scam Prevention","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Scamnetic","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pryon","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Pryon wins prestigious ai breakthrough award","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cortica","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cardiac Dimensions","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Inspire Medical Systems","companyUrl":null,"stage":"not stated","sector":"medical devices","investmentYear":null,"description":"Medical device company focused on implantable therapy for obstructive sleep apnea","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MOGL","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"How MOGL’s New Offering Turns Athlete Social Accounts Into Measurable Ad Channels","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Payment Labs","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"National Squash League Announces Payment Labs as Official Payments Partner","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Alaffia","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Alaffia named one of America’s Greatest Startup Workplaces by Newsweek","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Miach Orthopaedics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Neuros Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Shiratronics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ulab","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"XII Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Aclaris Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharmaceutical company developing immuno-inflammatory treatments","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Avedro","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Axonics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Medical device company focused on sacral neuromodulation for bladder and bowel dysfunction","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Bardy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Biohaven Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharmaceutical company developing treatments for neurological and other diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cameron Health","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Medical device company known for implantable cardiac technology","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cardiocore Lab","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CardioMEMS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ceptaris Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Ception Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Channel Medsystems","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Collegium Pharmaceutical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Specialty pharmaceutical company","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Concerro","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Conor Medsystems","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Medical device company focused on cardiovascular devices","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Devoro Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Endotronix","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Entrigue Surgical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Inspire Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Interlace Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Mako Surgical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Medical device company focused on robotic surgical systems","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Nalu","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Otonomy","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Serpex","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Shoulder Innovations","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Spirox","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"T2 Biosystems","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tarsus Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharmaceutical company developing eye-disease therapies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TherOx","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TransMolecular","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Trevi Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Biopharmaceutical company developing therapies for chronic cough and related conditions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Venus Concept","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"V-Wave Medical","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Xlumena","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":2,"partners":[{"id":22978,"name":"Tony Natale, M.D.","title":"Managing Partner","seniority":null,"focusTags":["medical technologies","orthopedics","ENT","ophthalmology","GI","women’s health","robotics","minimally invasive technologies"],"linkedinUrl":"https://www.linkedin.com/in/anthony-natale-m-d-683a4670","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":49334,"name":"Tony Natale,","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[{"id":117,"name":"Aperture Venture Partners II","vintageYear":2020,"sizeUsd":250000000,"status":"actively investing","focusAreas":[]},{"id":116,"name":"Aperture Venture Partners I","vintageYear":2015,"sizeUsd":150000000,"status":"fully deployed","focusAreas":[]}],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"news","title":"Aperture Venture Partners coverage page on MedCity News mentions INVEST Digital Health 2026","url":"https://medcitynews.com/tag/aperture-venture-partners/","source":"MedCity News","occurredAt":"2026-10-29T00:00:00.000Z"},{"kind":"news","title":"Aperture Venture Partners profile updated with recent investments including KOKO Medical","url":"https://www.cbinsights.com/investor/aperture-venture-partners","source":"CB Insights","occurredAt":"2026-10-25T00:00:00.000Z"},{"kind":"news","title":"VS3 Medical wins FDA breakthrough status for tinnitus implant; Aperture Venture Partners listed as an investor","url":"https://www.mpo-mag.com/breaking-news/vs3-medical-wins-fda-breakthrough-status-for-tinnitus-implant/","source":"MPO Magazine","occurredAt":"2026-09-29T00:00:00.000Z"},{"kind":"news","title":"Aperture Venture Capital recent news page with multiple 2026 portfolio updates","url":"https://aperturevc.com/","source":"Aperture Venture Capital","occurredAt":"2026-09-18T00:00:00.000Z"}],"contentUpdatedAt":"2026-11-02T18:07:29.497Z","investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":13762,"name":"NeuroNet Ventures","slug":"neuronet-ventures","logoUrl":null,"website":"https://neuronetgpo.com/","stageFocus":["Seed"],"sectorTags":["AI / ML"],"hqGeo":"Chicago, IL"},{"id":11767,"name":"LiftScale Partners","slug":"liftscale-partners","logoUrl":null,"website":"https://weareliftscale.com/","stageFocus":["Pre-Seed"],"sectorTags":["AI / ML","SaaS"],"hqGeo":"San Francisco, CA"},{"id":1574,"name":"Plaid Ventures","slug":"plaid-ventures","logoUrl":null,"website":"https://plaid.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","Developer Tools","AI / ML"],"hqGeo":"San Francisco, CA"},{"id":3892,"name":"Madrona Pioneer Fund","slug":"madrona-pioneer-fund","logoUrl":null,"website":"https://www.madrona.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Real Estate","SaaS","Enterprise","Security","Developer Tools"],"hqGeo":"Seattle, WA"},{"id":1621,"name":"Canary","slug":"canary","logoUrl":null,"website":"https://www.canary.capital/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Fintech","AI / ML","SaaS","Healthcare","Enterprise"],"hqGeo":"São Paulo, Brazil"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"saas","displayName":"SaaS Investors","pageType":"industry"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":"Aperture Venture Partners is a venture capital firm headquartered in Denver, CO. The firm focuses on applied AI within B2B SaaS applications, particularly in sectors like hospitality and customer personalization. Aperture Venture Partners invests at the pre-seed and seed stages across B2B SaaS, AI Personalization, Hospitality Tech, AI/ML, and Enterprise.\n\nThe firm typically deploys between $500K and $3.0M per investment. Aperture Venture Partners currently manages $101M in assets. Cold outreach is an accepted way to connect with the firm. The team includes specialists in medical technologies as well as B2B SaaS and Hospitality Tech.","portfolioNarrative":"Aperture Venture Partners has recorded investments in nine portfolio companies. These include Alaffia, Anonybit, BronX Medical Inc., InsightsNow, MOGL, Payment Labs, Pryon, Scamnetic, and WelcomeOS. Available records show investments in AI Personalization and Hospitality Tech among the sectors represented.\n\nThe firm continues to support early-stage companies that align with its applied AI focus in B2B SaaS, hospitality, and customer personalization.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-09-16T16:16:07.828Z"}